A 2-year follow-up study of cigarette smoking and risk of dementia

European Journal of Neurology

Volumn 11, Issue 4, 2004, Pages 277-282

  Juan, D ^a   Zhou, D H D ^a   Li, J ^a   Wang, J Y J ^a   Gao, C ^a   Chen, M ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cigarette smoking; Dementia; Elderly

Indexed keywords

ALCOHOL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CIGARETTE SMOKING; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; EDUCATION; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SEX;

AGED; ALZHEIMER DISEASE; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 1842834259     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00779.x     Document Type: Article

References (38)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, rev. American Psychiatric Association, Washington DC.
2. Antoniades C, Tousoulis D, Tentolouris C et al. (2003). Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost 89:990-995.
3. Bar KJ, Franke S, Wenda B et al. (2003). Pentosidine and N(varepsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging 24:333-338.
4. Brookmeyer R, Gray S, Kawas C (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88:1337-1342.
5. Cervilla JA, Prince M, Mann A (2000). Smoking, drinking and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry 68:622-626.
6. Crowley Weber CL, Dvorakova K, Crowley C et al. (2003). Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 145:53-66.
7. Demirovic J, Prineas R, Loewenstein D et al. (2003). Prevalence of dementia in three ethnic groups. The South Florida program on aging and health. Ann Epidemiol 13:472-478.
8. Esiri M, Nagy Z, Smith MZ, Barnetson L et al. (1999). Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354:919-920.
9. Folstein MF, Folstein SE, McHugh PR (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189-198.
10. Frisoni GB, Padovani A, Wahlund LO (2003). The diagnosis of Alzheimer disease before it is Alzheimer dementia. Arch Neurol 60:1023-1024.
11. Gaugler JE, Zarit SH, Pearlin LI (2003). The onset of dementia caregiving and its longitudinal implications. Psychol Aging 18:171-180.
12. Grasbeck A, Englund E, Horstmann V et al. (2003). Predictors of mortality in frontotemporal dementia: a retrospective study of the prognostic influence of pre-diagnostic features. Int J Geriatr Psychiatry 18:594-601.
13. Henderson AS, Jorm AF (1998). Dementia in Australia. Aged and Community Care Service Development and Evaluation Reports, no. 35. Commonwealth of Australia, Canberra.
14. How MN, Price IR (2001). Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia. Int Psychogeriatr 13:465-475.
15. Kiefe CI, Williams OD, Greelund KJ, Ulene V, Gardin JM, Raczynski JM (1998). Health care access and seven year change in cigarette smoking. Am J Prev Med 15:146-154.
16. Launer LJ, Andersen K, Dewey ME et al. (1999). Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM poole 2000 d analysis. Neurology 52:78-84.
17. Lee PN (1994). Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13:131-144.
18. Lindsay J, Laurin D, Verreault R et al. (2002). Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156:445-453.
19. Mack WJ, Islam T, Lee Z et al. (2003). Environmental tobacco smoke and carotid arterial stiffness. Prev Med 37:148-154.
20. Mckhann G, Drachman D, Folstein M et al. (1984). Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
21. Markesbery WR (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147.
22. Newhouse PA, Potter A, Levin ED (1997). Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Drugs Ageing 11:206-228.
23. O'Callaghan P, Meleady R, Fitzgerald T et al. (2002). Smoking and plasma homocysteine. Eur Heart J 23:1580-1586.
24. Olshan AF, Li R, Pankow JS et al. (2003). Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. Epidemiology 14:321-327.
25. Ott A, Breteler MMB, Harskamp F et al. (1998). Incidence and risk of dementia: the Rotterdam Study. Am J Epidemiol 147:574-580.
26. Polidori MC, Mecocci P, Stahl W, Sies H (2003). Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 90:147-150.
27. Riggs JE (1993). Smoking and Alzheimer 2000's disease: protective effect or differential survival bias? Lancet 342:793-794.
28. Romann GC, Tatemichi TK, Erkinjuntti T et al. (1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 34:250-260.
29. Schumock GT (1998). Economic considerations in the treatment and management of Alzheimer's disease. Am J Health Syst Pharm 55:17-21.
30. Skoog L (1998). Status of risk factors for vascular dementia. Neuroepidemiology 17:2-9.
31. Stockton MC, McMahon SD, Jason LA (2000). Gender and smoking behavior in a worksite smoking cessation program. Addict Behav 25:347-360.
32. Tune LE (2003). Great progress in diagnosis and treatment of dementia. Am J Geriatr Psychiatry 11:388-390.
33. Tyas SL, White LR, Petrovitch H et al. (2003). Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 24:589-596.
34. Ueta E, Tadokoro Y, Yamamoto T et al. (2003). The effect of cigarette smoke exposure and ascorbic Acid intake on gene expression of antioxidant enzymes and other related enzymes in the livers and lungs of shionogi rats with osteogenic disorders. Toxicol Sci 73:339-347.
35. USDHHS (1990). The Health Benefits of Smoking Cessation: a Report of the Surgeon General. US Govt Printing Office, Washington, DC.
36. Van Duijn CM, Clayton DG, Chandra V et al. (1994). Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genetics Epidemiol 11:539-551.
37. Zanardi A, Leo G, Biagini G et al. (2002). Nicotine and neurodegeneration in ageing. Toxicol Lett 127:207-215.
38. Zhou HD, Deng J, Li J et al. (2003). Study of the relationship between cigarette smoking, alcohol drinking and cognitive impairment among elderly people in China. Age and Aging 32:205-210.